Cambridgeshire Parkinsons Incidence from GP to Neurologist
Principal Investigator: Professor Roger Barker
Start date: 2000
Age at recruitment: 30+
Sample size at recruitment: 142
The CamPaIGN study is a longitudinal study of the natural history of incident Parkinson’s disease (PD) patients. The study was the first to prospectively track disease evolution from diagnosis in an unselected population-representative incident cohort, and has focused primarily on the evolution of cognitive dysfunction in PD, reporting on both clinical and genetic predictors of dementia. Other outcomes of interest in this study include development of dyskinesia, development of postural instability, and death.
John van Geest Centre for Brain Repair
E.D. Adrian Building
Funders (core support):
Medical Research Council (MRC)
The National Institutes of Health Research (NIHR)
Biomedical Research and the Cure Parkinson’s Trust
Anthropometric and physical: cardiovascular.
Psychological: cognitive function; mental health.
Lifestyle: smoking; alcohol.
Biological samples: blood.
Acknowledgement statement: We acknowledge and thank all the patients who are generously giving up their time to participate in the CamPaIGN study, as well as their carers. This study has received funding from the following sources: the Medical Research Council, the Wellcome Trust, the Patrick Berthoud Trust, and the NIHR Cambridge Biomedical Research Centre. We are also very grateful for the kind donations we have received from patients and the public to support this work.